Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'hcv'
hcv published presentations and documents on DocSlides.
Community Pharmacy Considerations for HIV
by tawny-fly
& HCV . Therapy. Larry Pineda, . PharmD. , . ...
Updates in Treatment of Hepatitis C
by myesha-ticknor
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
Use the Web Browser on Your Mobile Device to Participate in Polling*
by phoebe-click
Go to: pollev.com/CCO2. or scan the QR code below...
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Lesson 4 : Provider-Patient Interactions and
by natalia-silvester
Engagement . in . HIV/HCV . Care. Core Competency...
The Intersection of Opioids and Viral Hepatitis – A Public Health Crisis
by faustina-dinatale
Jonathan Mermin, MD, MPH. RADM, USPHS. Centers fo...
The Hepatitis Viruses Jayesh
by conchita-marotz
A. Patel, MD, DTM&H. Learning Your “A B C ...
Hepatitis C Overview 1 Updated 9/20/2017
by liane-varnes
2. Introduction . Self-Advocacy through Education...
What Aging Service Providers Need to Know about HIV and
by cheryl-pisano
HCV (Hepatitis . C . Virus). February 2015. Techn...
Updates on HIV, HIV Prevention, and
by kittie-lecroy
. HCV . testing and treatment. Lorenzo McFarland...
July 2017 Lesson 1: Chronic Hepatitis C
by phoebe-click
Virus Infection. Core Competency 3: Screening, Te...
Jorge Mera, MD, FACP Cherokee Nation Infectious Diseases
by jane-oiler
HCV: . From Diagnosis . to Cure. to Elimination ...
HIV 2015-2016: New Agents, New Strategies
by ellena-manuel
Learning Objectives. EARLY VS DEFERRED ART. The C...
HCV drug pricing « The future of HIV & HCV Treatment :
by marina-yarberry
Patents, pricing and pharma, Special session » ...
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
Taking Steps to Improve the Management
by mitsue-stanley
of Chronic HCV. This educational program and spea...
Resistance to Direct Acting Antiviral Therapy
by tawny-fly
Resistance to HCV DAAs: What is the threat level...
May 3, 2016: Hepatitis C Kills More Americans than Any Other Infectious
by luanne-stotts
Disease. Annual Hepatitis . C-related mortality i...
Hepatitis C and HIV Coinfection
by pamella-moone
Presented by: . Fabian Cretu, Beverly-Ann Oliver,...
AIDS CARE GROUP Grace Paik, CRNP
by marina-yarberry
Regina . Ubaldi. -Rosen, CRNP. ELLAH NOTA, CRNP. ...
Global Hepatitis C Guidelines 2014: recommendations for a public health approach
by olivia-moreira
Gottfried . Hirnschall. Background . HCV infectio...
Revised CSTE Case Definition for Acute and Chronic Hepatitis C, 2016
by calandra-battersby
CalREDIE Local Users Call. December 2, 2015. Rach...
Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient
by min-jolicoeur
Dr Dzintars Gotham MBBS BSc(Hons). on behalf of. ...
PEG alfa-2a RBV versus
by alexa-scheidler
. PEG alfa-. 2a . versus. INF RBV . APRICOT S...
Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease
by alida-meadow
SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...
Advances in the Treatment of
by danika-pritchard
HCV Genotype 3 and HIV/HCV Coinfection . What's S...
What’s New in Hepatitis C
by debby-jeon
Diana L. . Sylvestre. , MD. University of CA, San...
Ad Hoc Disease Transmission Advisory Committee (DTAC) Update
by alexa-scheidler
1. Spring 2018. Questions about reporting potenti...
July 2017 Lesson 1: Risk
by yoshiko-marsland
Behavior . Harm Reduction. Core Competency 2: . P...
National Viral Hepatitis Roundtable
by ellena-manuel
HCV Baby Boomer Screening . and . Linkage to Care...
Listening to the service user voice:
by yoshiko-marsland
advantages for service delivery design . Magdale...
Lessons Learned and Novel
by tatyana-admore
Investigation Techniques . in . Response to a Lar...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
Workshops, 2.15-3.15 North Central ODN, led by Professor William Rosenberg, Royal Free: In-reach tr
by trish-goza
Barts. ODN, led by Professor Graham Foster, . Ba...
High HIV, HBV and HCV
by stefany-barnette
Prevalence. . among. . People. . Who. . Injec...
www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com
by luanne-stotts
. HCV Training Workshop. Version 19.0. HCSP/HCV ...
H. Nina Kim, MD Assistant Professor of Medicine
by giovanna-bartolotta
Division of Infectious Diseases. University of Wa...
HIV and viral hepatitis co-infection
by cheryl-pisano
Wirach Maek-a-nantawat, MD.. 11 July 2011. Conte...
ALLY-3 Design Objective SVR
by mitsue-stanley
12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...
Load More...